Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
暂无分享,去创建一个
Iris Lansdorp-Vogelaar | Petur Snaebjornsson | I. Lansdorp-Vogelaar | P. Snaebjornsson | N. Hoogerbrugge | L. van der Kolk | A. Cats | Nicoline Hoogerbrugge | Tanya M Bisseling | Annemieke Cats | Rachel S van der Post | Jolanda van Dieren | Anna Grelack | Lizet E van der Kolk | J Han van Krieken | R. S. van der Post | T. Bisseling | J. V. van Dieren | J. V. van Krieken | A. Grelack | J. Van Krieken | T M Bisseling
[1] R. van Hillegersberg,et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers , 2015, Journal of Medical Genetics.
[2] Joo Ha Hwang,et al. Screening and surveillance for gastric cancer in the United States: Is it needed? , 2016, Gastrointestinal endoscopy.
[3] M. Fukayama,et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. , 2016, Gastrointestinal endoscopy.
[4] R. Jeffrey,et al. A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer , 2011, Annals of Surgical Oncology.
[5] J. Hwang,et al. Gastric intestinal metaplasia: An irreversible risk factor for gastric cancer? , 2016, Gastrointestinal endoscopy.
[6] B. Fernandez,et al. Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 Patients , 2009, Annals of Surgical Oncology.
[7] L. Vissers,et al. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing , 2017, European Journal of Human Genetics.
[8] E. Kuipers,et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. , 2011, European journal of cancer.
[9] D. Chung,et al. Prophylactic total gastrectomy for individuals with germline CDH1 mutation. , 2011, Surgery.
[10] H. Yoshida,et al. Association of Helicobacter pylori and diffuse type gastric cancer. , 1996, Journal of gastroenterology.
[11] Jing-Yuan Fang,et al. Comparison of the clinicopathological characteristics of young and Elderly patients with gastric carcinoma: A meta analysis , 2012, Journal of surgical oncology.
[12] M. Slattery,et al. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. , 1993, JAMA.
[13] L. Franzén,et al. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma , 2000, The British journal of surgery.
[14] Randall W Burt,et al. ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.
[15] T. Yoshimura,et al. Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989 , 2001, British Journal of Cancer.
[16] P. Guilford,et al. Giant gastric ulcer: an endoscopic roller coaster , 2005, Gut.
[17] R. Busuttil,et al. Intestinal metaplasia: A premalignant lesion involved in gastric carcinogenesis , 2009, Journal of gastroenterology and hepatology.
[18] J. Lennerz,et al. Endoscopic Surveillance of Patients With Hereditary Diffuse Gastric Cancer: Biopsy Recommendations After Topographic Distribution of Cancer Foci in a Series of 10 CDH1-mutated Gastrectomies , 2012, The American journal of surgical pathology.
[19] B. Fernandez,et al. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.
[20] A. Sézeur,et al. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study , 2013, Journal of Medical Genetics.
[21] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[22] J. Goldblatt,et al. The Western Australian family connections genealogical project: detection of familial occurrences of single gene and chromosomal disorders. , 2014, Genetic Testing and Molecular Biomarkers.
[23] A. Wagner,et al. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. , 2015, Gastroenterology.
[24] E. Kuipers,et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. , 2008, Gastroenterology.
[25] Takafumi Ando,et al. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: Data from a single institute over 30 years , 2007, Journal of gastroenterology and hepatology.
[26] Anthony E. Reeve,et al. E-cadherin germline mutations in familial gastric cancer , 1998, Nature.
[27] T. Hwang,et al. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger , 2012, Journal of surgical oncology.
[28] C. Caldas,et al. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. , 2014, Gastrointestinal endoscopy.
[29] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[30] A. Tavares,et al. Analysis of Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young and Older Patients , 2012, Pathology & Oncology Research.
[31] R. Bernards,et al. An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer , 2013, The Journal of pathology.
[32] J. Coebergh,et al. Gastric cancer: Decreasing incidence but stable survival in the Netherlands , 2014, Acta oncologica.
[33] V. Moyer,et al. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. , 2011, Epidemiologic reviews.
[34] J. Nattermann,et al. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients , 2016, Endoscopy International Open.